MedTrace Logo

Efficacy and Safety of Aspirin Therapy With CABG

NCT02942680 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2016-10-24

No results posted yet for this study

Summary

evaluate the safety of preoperative aspirin therapy when performing bypass surgery in conditions of artificial blood circulation

Conditions

Interventions

DRUG

acetylsalicylic acid started for 24 hours before surgery

DRUG

acetylsalicylic acid stayed for 5 days before surgery

Sponsors & Collaborators

  • Meshalkin Research Institute of Pathology of Circulation

    lead NETWORK

Principal Investigators

  • Alexander M. Chernyavskiy, MD PhD · Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology Ministry of Health care of Russian Federation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02942680 on ClinicalTrials.gov